<code id='BCE3B65706'></code><style id='BCE3B65706'></style>
    • <acronym id='BCE3B65706'></acronym>
      <center id='BCE3B65706'><center id='BCE3B65706'><tfoot id='BCE3B65706'></tfoot></center><abbr id='BCE3B65706'><dir id='BCE3B65706'><tfoot id='BCE3B65706'></tfoot><noframes id='BCE3B65706'>

    • <optgroup id='BCE3B65706'><strike id='BCE3B65706'><sup id='BCE3B65706'></sup></strike><code id='BCE3B65706'></code></optgroup>
        1. <b id='BCE3B65706'><label id='BCE3B65706'><select id='BCE3B65706'><dt id='BCE3B65706'><span id='BCE3B65706'></span></dt></select></label></b><u id='BCE3B65706'></u>
          <i id='BCE3B65706'><strike id='BCE3B65706'><tt id='BCE3B65706'><pre id='BCE3B65706'></pre></tt></strike></i>

          focus

          focus

          author:fashion    Page View:344
          om DiLenge (CQ in grey suit ) Flagship Pioneering Cambridge with US Congressman Raja Krishnamoorthi of Illinois were talking together at the event. Biotech companies demonstrating their medicines and materials at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge. The growing US backlash against the perceived national security threat posed by China's rising biotech industry
          Tom DiLenge of Flagship Pioneering (left) with U.S. Congressman Raja Krishnamoorthi of Illinois at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge, Mass. David L Ryan/The Boston Globe

          CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised national security concerns about Chinese penetration into key sectors of the U.S. economy, such as technology, manufacturing, and clean energy.

          Now, some in Congress are raising alarms about China’s threat to another vital industry: biotechnology.

          advertisement

          A bipartisan group of lawmakers visited Massachusetts this week to call attention to that threat and call for strengthening U.S. life sciences companies, protecting their technologies, and safeguarding Americans’ genetic data from a Chinese biotech industry with close ties to the authoritarian state.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          iTeos Therapeutics debuts first data on TIGIT
          iTeos Therapeutics debuts first data on TIGIT

          AdobeITeosTherapeuticsofferedthefirstlookatclinicaldataforitsexperimentalcancerantibodythatworksbybl

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          CDC wastewater surveillance dashboard to track bird flu hotspots

          GodofredoA.Vásquez/APReluctanceamongdairyfarmerstoreportH5N1birdfluoutbreakswithintheirherdsorallowt